208 related articles for article (PubMed ID: 37236758)
1. The roles of eicosanoids in myocardial diseases.
He Z; Wang DW
Adv Pharmacol; 2023; 97():167-200. PubMed ID: 37236758
[TBL] [Abstract][Full Text] [Related]
2. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.
Shi Z; He Z; Wang DW
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744996
[TBL] [Abstract][Full Text] [Related]
3. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.
Wang B; Wu L; Chen J; Dong L; Chen C; Wen Z; Hu J; Fleming I; Wang DW
Signal Transduct Target Ther; 2021 Feb; 6(1):94. PubMed ID: 33637672
[TBL] [Abstract][Full Text] [Related]
4. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
5. Regulation of inflammation in cancer by dietary eicosanoids.
Yang H; Rothenberger E; Zhao T; Fan W; Kelly A; Attaya A; Fan D; Panigrahy D; Deng J
Pharmacol Ther; 2023 Aug; 248():108455. PubMed ID: 37257760
[TBL] [Abstract][Full Text] [Related]
6. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
7. [Endogenous protective effects of arachidonic acid epoxygenase metabolites, epoxyeicosatrienoic acids, in cardiovascular system].
He ZW; Wang B; Chen C; Shi ZQ; Wang DW
Sheng Li Xue Bao; 2021 Aug; 73(4):617-630. PubMed ID: 34405218
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge.
Kiss L; Schütte H; Padberg W; Weissmann N; Mayer K; Gessler T; Voswinckel R; Seeger W; Grimminger F
Eur Respir J; 2010 Nov; 36(5):1088-98. PubMed ID: 20378604
[TBL] [Abstract][Full Text] [Related]
10. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.
Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and vascular stability in eicosanoids and cancer.
Hu J; Frömel T; Fleming I
Cancer Metastasis Rev; 2018 Sep; 37(2-3):425-438. PubMed ID: 29808461
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.
Panigrahy D; Kaipainen A; Greene ER; Huang S
Cancer Metastasis Rev; 2010 Dec; 29(4):723-35. PubMed ID: 20941528
[TBL] [Abstract][Full Text] [Related]
13. EET signaling in cancer.
Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC
Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066
[TBL] [Abstract][Full Text] [Related]
14. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
[TBL] [Abstract][Full Text] [Related]
15. Regulation of inflammation in cancer by eicosanoids.
Greene ER; Huang S; Serhan CN; Panigrahy D
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):27-36. PubMed ID: 21864702
[TBL] [Abstract][Full Text] [Related]
16. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
[TBL] [Abstract][Full Text] [Related]
17. Non-prostaglandin eicosanoids in fever and anapyrexia.
Kozak W; Fraifeld V
Front Biosci; 2004 Sep; 9():3339-55. PubMed ID: 15353362
[TBL] [Abstract][Full Text] [Related]
18. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.
Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR
PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
Huang H; Al-Shabrawey M; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():45-53. PubMed ID: 26747234
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
